HK1187366A1 - 新型細菌及所述細菌提取物、以及其在皮膚病中的用途 - Google Patents

新型細菌及所述細菌提取物、以及其在皮膚病中的用途

Info

Publication number
HK1187366A1
HK1187366A1 HK14100183.1A HK14100183A HK1187366A1 HK 1187366 A1 HK1187366 A1 HK 1187366A1 HK 14100183 A HK14100183 A HK 14100183A HK 1187366 A1 HK1187366 A1 HK 1187366A1
Authority
HK
Hong Kong
Prior art keywords
bacterium
dermatology
extracts
same
novel
Prior art date
Application number
HK14100183.1A
Other languages
English (en)
Inventor
．萊巴榮
．布蘭
．卡斯泰-里西
．源
Original Assignee
皮埃爾．法布爾皮膚化妝品公司
皮埃爾和瑪利居里大學
巴黎第六大學
法國
國家科學研究中心
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44359781&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1187366(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 皮埃爾．法布爾皮膚化妝品公司, 皮埃爾和瑪利居里大學, 巴黎第六大學, 法國, 國家科學研究中心 filed Critical 皮埃爾．法布爾皮膚化妝品公司
Publication of HK1187366A1 publication Critical patent/HK1187366A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/007—Preparations for dry skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/10—Washing or bathing preparations
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/36—Neisseria

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Birds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
HK14100183.1A 2010-12-22 2014-01-08 新型細菌及所述細菌提取物、以及其在皮膚病中的用途 HK1187366A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1061081A FR2969657B1 (fr) 2010-12-22 2010-12-22 Nouvelle bacterie et extraits de ladite bacterie et leur utilisation en dermatologie
PCT/EP2011/073747 WO2012085182A1 (en) 2010-12-22 2011-12-22 Novel bacterium and extracts of said bacterium and the use of same in dermatology

Publications (1)

Publication Number Publication Date
HK1187366A1 true HK1187366A1 (zh) 2014-04-04

Family

ID=44359781

Family Applications (1)

Application Number Title Priority Date Filing Date
HK14100183.1A HK1187366A1 (zh) 2010-12-22 2014-01-08 新型細菌及所述細菌提取物、以及其在皮膚病中的用途

Country Status (30)

Country Link
US (2) US9084811B2 (zh)
EP (1) EP2655595B1 (zh)
JP (2) JP6117111B2 (zh)
KR (1) KR102043472B1 (zh)
CN (1) CN103403144B (zh)
AR (1) AR084454A1 (zh)
AU (1) AU2011347254B2 (zh)
BR (1) BR112013015998A2 (zh)
CA (1) CA2821653C (zh)
CL (1) CL2013001853A1 (zh)
CO (1) CO6741177A2 (zh)
DK (1) DK2655595T3 (zh)
ES (1) ES2689138T3 (zh)
FR (1) FR2969657B1 (zh)
GE (1) GEP201606589B (zh)
HK (1) HK1187366A1 (zh)
IL (1) IL226943B (zh)
MA (1) MA34734B1 (zh)
MX (1) MX345125B (zh)
MY (1) MY173066A (zh)
NZ (1) NZ612294A (zh)
PL (1) PL2655595T3 (zh)
PT (1) PT2655595T (zh)
RU (1) RU2612790C2 (zh)
SG (1) SG191236A1 (zh)
TN (1) TN2013000249A1 (zh)
TW (1) TW201307551A (zh)
UA (1) UA113399C2 (zh)
WO (1) WO2012085182A1 (zh)
ZA (1) ZA201304355B (zh)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013190106A1 (en) * 2012-06-21 2013-12-27 Pierre Fabre Medicament Use of a live bacterium for the treatment of intestinal inflammatory disorders
CA2924690A1 (en) 2013-09-25 2015-04-02 Vertex Pharmaceuticals Incorporated Imidazopyridazines useful as inhibitors of the par-2 signaling pathway
FR3065009B1 (fr) * 2017-04-06 2020-11-27 Fabre Pierre Dermo Cosmetique Secretome bacterien pour son utilisation dans le traitement des lesions cutanees
FR3081705B1 (fr) 2018-06-01 2020-12-04 Fabre Pierre Dermo Cosmetique Extrait et composition dermatologique le comprenant pour le traitement des peaux sensibles
FR3114024B1 (fr) 2020-09-11 2022-09-09 Fabre Pierre Dermo Cosmetique Nouvelle émulsion mimant la peau

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2075221T3 (es) * 1989-10-06 1995-10-01 Janos Szabo Proceso para la preparacion de una composicion farmaceutica para el tratamiento de las enfermedades de la piel, especialmente las dermatitis piogenas y atopicas.
CH680045A5 (zh) * 1990-02-16 1992-06-15 Om Lab Sa
RU2188029C2 (ru) * 1995-09-07 2002-08-27 Л'Ореаль Применение экстракта из нефотосинтезирующей нитчатой бактерии и содержащая его композиция
US7807181B2 (en) * 2002-03-20 2010-10-05 Emory University Neisseria mutants, lipooligosaccharides and immunogenic compositions
GB0321615D0 (en) 2003-09-15 2003-10-15 Glaxo Group Ltd Improvements in vaccination
US20050163764A1 (en) 2003-09-22 2005-07-28 Yale University Treatment with agonists of toll-like receptors
US7244607B2 (en) * 2003-10-01 2007-07-17 The United States Of America, As Represented By The Secretary Of Agriculture Chromobacterium subtsugae sp. nov. for control of insect pests
EP3332791A1 (en) * 2007-03-05 2018-06-13 OM Pharma Bacterial extract for respiratory disorders and process for its preparation
FR2918885B1 (fr) * 2007-07-17 2009-08-28 Oreal Utilisation d'extrait de bacterie cultivee sur eau thermale pour diminuer les poches et/ou les cernes perioculaires
FR2918884B1 (fr) * 2007-07-17 2010-01-15 Oreal Utilisation d'extraits bacteriens cultives sur eau thermale comme agent anti-rougeur
FR2918883B1 (fr) * 2007-07-17 2010-01-15 Oreal Utilisation d'un extrait bacterien cultive sur une eau thermale pour le traitement des peaux seches
EP2274320A1 (en) * 2008-04-25 2011-01-19 ID Biomedical Corporation of Quebec Methods for preparing immunogenic compositions
CN102046198A (zh) 2008-04-25 2011-05-04 系统生物学研究所 鞭毛蛋白多肽疫苗
SI22889A (sl) 2008-10-28 2010-04-30 Kemijski inštitut Himerni flagelini za cepiva
WO2010135704A2 (en) 2009-05-22 2010-11-25 Institute For Systems Biology Secretion-related bacterial proteins for nlrc4 stimulation
KR101762610B1 (ko) * 2010-11-05 2017-08-04 삼성전자주식회사 이동 통신 시스템에서 역방향 스케줄링 및 그를 위한 정보 전송 방법 및 장치

Also Published As

Publication number Publication date
FR2969657B1 (fr) 2014-02-07
US20130316033A1 (en) 2013-11-28
CL2013001853A1 (es) 2014-03-28
CN103403144A (zh) 2013-11-20
UA113399C2 (xx) 2017-01-25
EP2655595B1 (en) 2018-07-04
GEP201606589B (en) 2017-01-10
MX345125B (es) 2017-01-17
ZA201304355B (en) 2014-11-26
TN2013000249A1 (en) 2014-11-10
US20150231187A1 (en) 2015-08-20
JP2014503211A (ja) 2014-02-13
JP2017099393A (ja) 2017-06-08
FR2969657A1 (fr) 2012-06-29
NZ612294A (en) 2015-05-29
AU2011347254A1 (en) 2013-07-11
CO6741177A2 (es) 2013-08-30
MX2013007217A (es) 2014-01-08
EP2655595A1 (en) 2013-10-30
KR20140030109A (ko) 2014-03-11
CA2821653A1 (en) 2012-06-28
PT2655595T (pt) 2018-11-02
MA34734B1 (fr) 2013-12-03
CA2821653C (en) 2020-03-10
US9662357B2 (en) 2017-05-30
BR112013015998A2 (pt) 2017-04-11
MY173066A (en) 2019-12-23
AR084454A1 (es) 2013-05-15
JP6117111B2 (ja) 2017-04-19
TW201307551A (zh) 2013-02-16
AU2011347254B2 (en) 2016-07-14
ES2689138T3 (es) 2018-11-08
RU2013132895A (ru) 2015-01-27
WO2012085182A1 (en) 2012-06-28
DK2655595T3 (en) 2018-10-08
US9084811B2 (en) 2015-07-21
IL226943B (en) 2019-02-28
RU2612790C2 (ru) 2017-03-13
SG191236A1 (en) 2013-07-31
KR102043472B1 (ko) 2019-11-11
PL2655595T3 (pl) 2019-07-31
CN103403144B (zh) 2015-11-25

Similar Documents

Publication Publication Date Title
HUS2100032I1 (hu) Helyettesített 5-fluor-1H-pirazolopiridin-származékok és alkalmazásuk
HK1187049A1 (zh) 雙芳基連接的芳基三唑酮及其用途
HK1184488A1 (zh) 人體促進細胞及其用途
ZA201208173B (en) Peptices and their use
HK1184363A1 (zh) 新的 衍生物及其用途
PL2469142T3 (pl) Złączka zaciskowa i jej zastosowanie
PT2605757E (pt) Formulações à base de nalbufina e suas utilizações
HRP20182083T1 (hr) Nova kombinacija i uporaba
EP2402429A4 (en) EQUOL-PRODUCING BACTERIUM AND ITS USE
PT2521445T (pt) Formulação e utilização da mesma
GB2480515B (en) Lacquer composition and use thereof
ZA201302854B (en) Substituted benzamides and their uses
HK1187366A1 (zh) 新型細菌及所述細菌提取物、以及其在皮膚病中的用途
PT2563806E (pt) Leucolectinas humanas e suas utilizações
EP2608785A4 (en) LIPOMA CYCLES AND ITS USES
ZA201304460B (en) Novel bacterium and extracts of said bacterium and the use of same in therapy
EP2529013A4 (en) NOVEL BETA GLUCOSIDASE AND USES THEREOF
EP2619571A4 (en) HUMAN B1 CELLS AND APPLICATIONS THEREOF
EP2657236A4 (en) NEW 2-ALKYNYL-N9-PROPARGYLADENINE AND ITS MEDICAL USE